Literature DB >> 25148895

Involvement of chromosome region maintenance 1 (CRM1) in the formation and progression of esophageal squamous cell carcinoma.

Xiaojing Yang1, Lei Cheng, Li Yao, Hanru Ren, Shu Zhang, Xiao Min, Xueyu Chen, Jianguo Zhang, Mei Li.   

Abstract

Chromosome region maintenance 1 (CRM1) has been related to several malignancies. The predictive value of CRM1 in the malignance and prognosis of esophageal squamous cell carcinoma (ESCC), however, is not clear yet. In this study, we displayed that CRM1 expression was up-regulated in ESCC using immunohistochemistry and Western blot. Statistical analysis demonstrated that patients with high CRM1 levels indicated shorter survival period. We further found that silencing CRM1 caused apoptosis in ESCC cell lines. Moreover, knockdown of CRM1 disturbed the expression of tumor suppressor proteins and inhibited NF-κB activity in ESCC cell lines, especially if the cell line was treated with 5-fluorouracil. In consequence, our results for the first time indicated that CRM1 was dysregulated in ESCC, and suppression of CRM1 expression which resulted in inhibiting of NF-κB signaling might be developed into a new strategy in ESCC therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25148895     DOI: 10.1007/s12032-014-0155-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  37 in total

1.  Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.

Authors:  Noushin Taghavi; Firouzeh Biramijamal; Masoud Sotoudeh; Omeed Moaven; Hooman Khademi; Mohammad Reza Abbaszadegan; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

2.  A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.

Authors:  Fang Tian; Tianli Fan; Yanan Jiang; Xiaoyan Zhang; Xinhua Wang
Journal:  Pathol Res Pract       Date:  2011-12-18       Impact factor: 3.250

3.  Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.

Authors:  Wei Wang; Lexun Xue; Pengju Wang
Journal:  Med Oncol       Date:  2010-02-09       Impact factor: 3.064

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 5.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

6.  CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.

Authors:  Y-T Tai; Y Landesman; C Acharya; Y Calle; M Y Zhong; M Cea; D Tannenbaum; A Cagnetta; M Reagan; A A Munshi; W Senapedis; J R Saint-Martin; T Kashyap; S Shacham; M Kauffman; Y Gu; L Wu; I Ghobrial; F Zhan; A L Kung; S A Schey; P Richardson; N C Munshi; K C Anderson
Journal:  Leukemia       Date:  2013-04-16       Impact factor: 11.528

7.  Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.

Authors:  Jianguo Zhang; Xiaojing Yang; Yuchan Wang; Hui Shi; Chengqi Guan; Li Yao; Xianting Huang; Zongmei Ding; Yuejiao Huang; Huijie Wang; Chun Cheng
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

8.  Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.

Authors:  Aiguo Shen; Yuchan Wang; Yueming Zhao; Lin Zou; Linlin Sun; Chun Cheng
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

9.  Low expression of cyclic AMP response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma.

Authors:  Yuchan Wang; Shuhui Zhou; Xiaojing Yang; Hui Shi; Mei Li; Qun Xue; Xianting Huang; Xinxiu Wang; Huijie Wang; Jianguo Zhang
Journal:  Tumour Biol       Date:  2013-08-09

10.  The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.

Authors:  Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

View more
  5 in total

1.  Expression of chromosomal regional maintenance protein-1 may be associated with subcellular survivin expression in human gastric and colorectal carcinoma.

Authors:  Michiko Shintani; Akito Tashiro; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Oncol Lett       Date:  2016-10-04       Impact factor: 2.967

Review 2.  Inhibiting cancer cell hallmark features through nuclear export inhibition.

Authors:  Qingxiang Sun; Xueqin Chen; Qiao Zhou; Ezra Burstein; Shengyong Yang; Da Jia
Journal:  Signal Transduct Target Ther       Date:  2016-07-01

3.  Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver.

Authors:  Qiao-Ling Xie; Yue Liu; Ying Zhu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

4.  CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis.

Authors:  Lu Yue; Zhen-Ni Sun; Ya-Sai Yao; Zan Shen; Hai-Bo Wang; Xiang-Ping Liu; Fang Zhou; Jin-Yu Xiang; Ru-Yong Yao; Hai-Tao Niu
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

5.  Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway.

Authors:  Qianqian Shan; Shengsheng Li; Qiyu Cao; Chenglong Yue; Mingshan Niu; Xiangyu Chen; Lin Shi; Huan Li; Shangfeng Gao; Jun Liang; Rutong Yu; Xuejiao Liu
Journal:  Korean J Physiol Pharmacol       Date:  2020-05-01       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.